Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Timed short messaging service improves adherence and virological outcomes in HIV-1-infected patients with suboptimal adherence to antiretroviral therapy.
Ammassari A, Trotta MP, Shalev N, Tettoni MC, Maschi S, Di Sora F, Orofino G, d'Ettorre G, Bai F, Celesia MB, Quiros Roldan E, Maserati R, Sterrantino G, Tommasi C, Boumis E, Iardino MR, Antinori A. Ammassari A, et al. Among authors: tommasi c. J Acquir Immune Defic Syndr. 2011 Dec 1;58(4):e113-5. doi: 10.1097/QAI.0b013e3182359d2a. J Acquir Immune Defic Syndr. 2011. PMID: 22033235 No abstract available.
Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens.
Svicher V, Alteri C, Artese A, Forbici F, Santoro MM, Schols D, Van Laethem K, Alcaro S, Costa G, Tommasi C, Zaccarelli M, Narciso P, Antinori A, Ceccherini-Silberstein F, Balzarini J, Perno CF. Svicher V, et al. Among authors: tommasi c. J Acquir Immune Defic Syndr. 2010 Nov;55(3):336-44. doi: 10.1097/QAI.0b013e3181e6763f. J Acquir Immune Defic Syndr. 2010. PMID: 20739898
Impact of pre-therapy viral load on virological response to modern first-line HAART.
Santoro MM, Armenia D, Alteri C, Flandre P, Calcagno A, Santoro M, Gori C, Fabeni L, Bellagamba R, Borghi V, Forbici F, Latini A, Palamara G, Libertone R, Tozzi V, Boumis E, Tommasi C, Pinnetti C, Ammassari A, Nicastri E, Buonomini A, Svicher V, Andreoni M, Narciso P, Mussini C, Antinori A, Ceccherini-Silberstein F, Di Perri G, Perno CF. Santoro MM, et al. Among authors: tommasi c. Antivir Ther. 2013;18(7):867-76. doi: 10.3851/IMP2531. Epub 2013 Jan 23. Antivir Ther. 2013. PMID: 23343501 Free article.
Maraviroc as intensification strategy in HIV-1 positive patients with deficient immunological response: an Italian randomized clinical trial.
Rusconi S, Vitiello P, Adorni F, Colella E, Focà E, Capetti A, Meraviglia P, Abeli C, Bonora S, D'Annunzio M, Di Biagio A, Di Pietro M, Butini L, Orofino G, Colafigli M, d'Ettorre G, Francisci D, Parruti G, Soria A, Buonomini AR, Tommasi C, Mosti S, Bai F, Di Nardo Stuppino S, Morosi M, Montano M, Tau P, Merlini E, Marchetti G. Rusconi S, et al. Among authors: tommasi c. PLoS One. 2013 Nov 14;8(11):e80157. doi: 10.1371/journal.pone.0080157. eCollection 2013. PLoS One. 2013. PMID: 24244635 Free PMC article. Clinical Trial.
Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels.
Santoro MM, Fabeni L, Armenia D, Alteri C, Di Pinto D, Forbici F, Bertoli A, Di Carlo D, Gori C, Carta S, Fedele V, D'Arrigo R, Berno G, Ammassari A, Pinnetti C, Nicastri E, Latini A, Tommasi C, Boumis E, Petrosillo N, D'Offizi G, Andreoni M, Ceccherini-Silberstein F, Antinori A, Perno CF. Santoro MM, et al. Among authors: tommasi c. Clin Infect Dis. 2014 Apr;58(8):1156-64. doi: 10.1093/cid/ciu020. Epub 2014 Jan 14. Clin Infect Dis. 2014. PMID: 24429430 Free article.
Prevalence and Associated Factors of Neurocognitive Impairment in HIV-Positive Patients on Effective Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Treatment.
Giancola ML, Balestra P, Ammassari A, Ricottini M, Lorenzini P, Angeletti C, Bellagamba R, Tommasi C, Tempestilli M, Zaccarelli M, Pinnetti C, Gallo AL, Antinori A, Narciso P, Nicastri E. Giancola ML, et al. Among authors: tommasi c. AIDS Res Hum Retroviruses. 2018 Nov;34(11):907-908. doi: 10.1089/AID.2018.0074. Epub 2018 Jul 23. AIDS Res Hum Retroviruses. 2018. PMID: 29929374 No abstract available.
Randomized clinical trial on efficacy of fixed-dose efavirenz/tenofovir/emtricitabine on alternate days versus continuous treatment.
Bellagamba R, Giancola ML, Tommasi C, Piselli P, Tempestilli M, Angeletti C, Zaccarelli M, Ammassari A, Pinnetti C, Gallo AL, Antinori A, Narciso P, Nicastri E; ATAD Study Group. Bellagamba R, et al. Among authors: tommasi c. AIDS. 2019 Mar 1;33(3):493-502. doi: 10.1097/QAD.0000000000002067. AIDS. 2019. PMID: 30702517 Clinical Trial.
Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort.
Pinnetti C, Di Giambenedetto S, Maggiolo F, Lorenzini P, Fabbiani M, Tommasi C, Latini A, Ammassari A, Loiacono L, Sterrantino G, Bellagamba R, Boumis E, Antinori A, Zaccarelli M. Pinnetti C, et al. Among authors: tommasi c. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19812. doi: 10.7448/IAS.17.4.19812. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25397556 Free PMC article.
Randomized trial of DRV/r or LPV/r QD monotherapy vs maintaining a PI/r-based antiretroviral regimen in persons with suppressed HIV replication.
Pinnetti C, Lorenzini P, Cozzi-Lepri A, Sandrine O, Tommasi C, Zaccarelli M, Perno CF, Capobianchi MR, Girardi E, Antinori A, Ammassari A. Pinnetti C, et al. Among authors: tommasi c. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19809. doi: 10.7448/IAS.17.4.19809. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25397553 Free PMC article.
Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfection.
Weimer LE, Fragola V, Floridia M, Guaraldi G, Ladisa N, Francisci D, Bellagamba R, Degli Antoni A, Parruti G, Giacometti A, Manconi PE, Vivarelli A, D'Ettorre G, Mura MS, Cicalini S, Preziosi R, Sighinolfi L, Verucchi G, Libertone R, Tavio M, Sarmati L, Bucciardini R; ISS-NIA Study Group. Weimer LE, et al. J Antimicrob Chemother. 2013 Jan;68(1):193-9. doi: 10.1093/jac/dks341. Epub 2012 Sep 14. J Antimicrob Chemother. 2013. PMID: 22984206 Free PMC article.
125 results